Holen Sie sich die Stockscreener-App
14.45
0.14%
-0.02
Handel nachbörslich:
14.50
0.05
+0.35%
Schlusskurs vom Vortag:
$14.47
Offen:
$14.59
24-Stunden-Volumen:
2.03M
Relative Volume:
1.16
Marktkapitalisierung:
$2.24B
Einnahmen:
$363.55M
Nettoeinkommen (Verlust:
$-78.68M
KGV:
-28.90
EPS:
-0.5
Netto-Cashflow:
$50.74M
1W Leistung:
+4.11%
1M Leistung:
+34.67%
6M Leistung:
+28.67%
1J Leistung:
-10.58%
1-Tages-Spanne:
$14.09
$14.62
1-Wochen-Bereich:
$13.35
$14.67
52-Wochen-Spanne:
$8.635
$17.94
Certara Inc Stock (CERT) Company Profile
Firmenname
Certara Inc
Sektor
Branche
Telefon
(415) 237-8272
Adresse
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Vergleichen Sie CERT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
14.45 | 2.24B | 363.55M | -78.68M | 50.74M | -0.50 |
|
VEEV
Veeva Systems Inc
|
215.78 | 36.24B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
52.40 | 9.99B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
43.23 | 7.43B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
83.45 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.45 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-09-27 | Hochstufung | UBS | Neutral → Buy |
| 2024-04-10 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-10 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-04-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Eingeleitet | Berenberg | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-01 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-11 | Hochstufung | Jefferies | Hold → Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Eingeleitet | BofA Securities | Buy |
| 2021-01-05 | Eingeleitet | Credit Suisse | Neutral |
| 2021-01-05 | Eingeleitet | Jefferies | Hold |
| 2021-01-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Certara Inc Aktie (CERT) Neueste Nachrichten
3 Momentum Stocks That Could Soar Post-Market Volatility - Investing.com
3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat
Where are the Opportunities in (CERT) - news.stocktradersdaily.com
Geode Capital Management LLC Sells 10,953 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Computer Aided Drug Discovery Market Future Prospects 2030 | Certara, Chemical Computing Group - openPR.com
LPL Financial LLC Increases Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? - MSN
Certara, Inc. (NASDAQ:CERT) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Certara (NASDAQ:CERT) Stock Price Expected to Rise, KeyCorp Analyst Says - Defense World
Certara FY2025 EPS Estimate Increased by Leerink Partnrs - Defense World
Equities Analysts Set Expectations for Certara Q1 Earnings - Defense World
Leerink Partnrs Has Positive Outlook of Certara Q1 Earnings - Defense World
Certara Inc (CERT) Shares Gap Down to $13.69 on Apr 15 - GuruFocus
Certara expects Q1 sales above estimates - MSN
William Blair Analysts Lower Earnings Estimates for Certara - Defense World
Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga
Certara, Inc.'s (NASDAQ:CERT) 32% Price Boost Is Out Of Tune With Revenues - simplywall.st
O Shaughnessy Asset Management LLC Has $138,000 Stake in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara (CERT) Exceeds Revenue Expectations with Strong Q1 Growt - GuruFocus
Certara (CERT) Explores Strategic Options for Regulatory Services Unit | CERT Stock News - GuruFocus
Certara (CERT) Reaffirms 2025 Financial Projections | CERT Stock News - GuruFocus
Why Certara Inc. (CERT) Soared Last Week? - MSN
Why Certara Inc. (CERT) Skyrocketed On Monday? - MSN
Certara (CERT) Secures One-Year Lock-Up Agreement with Arsenal C - GuruFocus
Certara's Stock Soars on Strong Revenue Guidance and AI-Driven Innovations - GuruFocus
Certara (CERT) Reports Strong Growth in Q1 2024 Performance | CE - GuruFocus
Certara launches Non-Animal Navigator for drug development By Investing.com - Investing.com South Africa
Certara announces Q1 revenue growth and $100 million buyback By Investing.com - Investing.com South Africa
Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report - Benzinga
Certara Launches Product for Biopharmaceutical Firms to Reduce Reliance on Animal Testing - marketscreener.com
Certara IncEntered Into Amendment To Previously Disclosed Letter Agreement Between Co And Arsenal Saturn Holdings Lp - MarketScreener
Certara Launches Non-Animal Navigator™ Solution to Help Drug Dev - GuruFocus
Certara announces Q1 revenue growth and $100 million buyback - Investing.com Australia
Certara (CERT) Introduces Non-Animal Navigator to Advance Precli - GuruFocus
Certara launches Non-Animal Navigator for drug development - Investing.com
Certara's Preliminary Q1 Revenue Increases; Reiterates 2025 Outlook; Authorizes $100 Million Share Buyback Plan - MarketScreener
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing - MarketScreener
Certara Launches Non- Animal Navigator?? Solution to Help Drug Developers Reduce Reliance on Animal Testing - marketscreener.com
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization - The Manila Times
Certara Delivers Strong Q1: Software Revenue Surges 18%, Unveils Major Buyback Plan - Stock Titan
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio? - Benzinga
Robert W. Baird Raises Certara (NASDAQ:CERT) Price Target to $13.00 - Defense World
10 Firms Defy Market Slump, Record Double-Digit Gains Last Week - Insider Monkey
Certara Inc (CERT) Shares Up 18.36% on Apr 11 - GuruFocus
Certara (CERT) Receives Price Target Boost Following FDA Biosimu - GuruFocus
Barclays Has Lowered Expectations for Certara (NASDAQ:CERT) Stock Price - Defense World
Certara (NASDAQ:CERT) Shares Gap Up After Analyst Upgrade - Defense World
Finanzdaten der Certara Inc-Aktie (CERT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
1.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):